From: General practitioners’ views on polypharmacy and its consequences for patient health care
Measure | Patient record | Telephone interviews with physicians | Telephone interviews with medical assistants | Practice registration form |
---|---|---|---|---|
Structure of practice | ||||
Sociodemographic data of physicians | √ | |||
Number of years worked as a physician / medical assistant | √ | √ | √ | |
Type of practice (e.g. single or community practice) | √ | |||
Patient characteristics | ||||
Number of patients quartlerly | √ | |||
Sociodemographic data of patients | √ | |||
Percentage of patients older than 65 years | √ | |||
Diagnosis of patient | √ | |||
Patients participation in chronic care programs | √ | |||
Patients number of doctor visits | √ | |||
Medication | ||||
Long-term and acute medication (e.g. dosage and active ingredients) | √ | |||
Other therapies and interventions as well as their frequency and duration (e.g. physiotherapy, patient education and rehabilitation) | √ | |||
Weighting of influencing factors during medication prescription | √ | |||
Noncompliance of patients receiving polypharmacy | √ | |||
Reports of adverse events, interactions or other consequences of polypharmacy | √ | √ | √ | |
Describing typical patients, reporting problems with medication | √ | |||
Taking account of recommendations in the PRISCUS-List | √ | |||
Organization and processes in practice | ||||
Needed time for treating patients receiving polypharmacy | √ | √ | ||
Difficulties on patient admission | √ | |||
Potential for changing practice organization to improve the treatment of patients receiving polypharmacy | √ | √ | ||
Potential and difficulties concerning cooperation with pharmacies | √ | |||
Use of individual case vignettes in practice | √ | |||
Evidence of formal qualifications of medical assistants | √ | √ |